New Delhi, India

Fortis Escorts Heart Institute

Heart Diseases

Heart Failure

Atrial Fibrillation

Septic Shock

Coronary Artery Disease

Myocardial Ischemia

Cardiac Sudden Death

Bundle-Branch Block

Myocardial Infarction

Hemorrhage

Dabigatran

EMPagliflozin

Warfarin

Idarucizumab

Empagliflozin

Boehringer Ingelheim

Medtronic

Abbott

Population Health Research Institute (PHRI)

Tata Memorial Centre

condition

Bradycardia

allSponsorName

gender

Male

Female

overallStatus

Recruiting

Not yet recruiting

Active, not recruiting

Enrolling by invitation

Completed

Terminated

Withdrawn

Suspended

Unknown

type

Interventional

Observational

Expanded Access

phase

Early Phase 1

Phase 1

Phase 2

Phase 3

Phase 4

Not Applicable

funderTypes

Industry

Other U.S. Federal agency

All others

ageGroup

Child (birth-17)

Adult (18-64)

Older Adult (65+)

The objective of this study is to evaluate the safety and effectiveness of LBBA pacing/sensing in patients implanted with the Tendril STS 2088TC or UltiPace LPA1231 lead through 6 months post-implant.

Left Bundle Branch Area Pacing (LBBAP) PMCF Study

Fortis Escorts Heart Institute | New Delhi, India

Site insights

Work at this site?

Active trials

Left Bundle Branch Area Pacing (LBBAP) PMCF Study (LBBAP PMCF)

Trial sponsors